Literature DB >> 2213392

Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana.

D A Frank1, H Bauchner, S Parker, A M Huber, K Kyei-Aboagye, H Cabral, B Zuckerman.   

Abstract

The relationship of maternal use of marijuana and cocaine during pregnancy to measures of neonatal body proportionality and body composition was assessed in a multiethnic sample of 1082 newborn infants. Maternal use of marijuana and cocaine during pregnancy was ascertained by self-report and by an enzyme-multiplied immunoassay technique for screening of urine samples obtained prenatally and again post partum. After each substance was analytically controlled for use of the other and for other potentially confounding variables, detection of marijuana metabolites in maternal urine was associated (p less than 0.05) with depressed mean arm muscle circumference and nonfat area of the arm but not with any measure of neonatal fatness. In contrast, detection of cocaine in maternal urine was associated (p less than 0.05) with decrements of subscapular fat folds and of the fat and nonfat areas of the arm. Although both substances were associated with depressed birth weight, there was no decrement of neonatal ponderal index or of the arm circumference/head circumference ratio in association with exposure to either substance. We conclude that both marijuana exposure and cocaine exposure during pregnancy are associated with symmetric intrauterine growth retardation, but that deficits are in differing compartments of intrauterine growth. These findings suggest that marijuana may retard fetal growth through maternal-fetal hypoxia, whereas cocaine may alter nutrient transfer to the fetus and fetal metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213392     DOI: 10.1016/s0022-3476(05)80702-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome.

Authors:  L Singer; R Arendt; K Farkas; S Minnes; J Huang; T Yamashita
Journal:  Dev Psychopathol       Date:  1997

Review 2.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

3.  Newborn Patients of Mothers with Substance Abuse: Providing proper health care for mothers and their babies.

Authors:  S G Albersheim
Journal:  Can Fam Physician       Date:  1991-08       Impact factor: 3.275

4.  Fetal Cocaine Exposure: Neurologic Effects and Sensory-Motor Delays.

Authors:  Robert E Arendt; Sonnia Minnes; Lynn T Singer
Journal:  Phys Occup Ther Pediatr       Date:  1996-01       Impact factor: 2.360

5.  Endocannabinoid regulation in human endometrium across the menstrual cycle.

Authors:  Jessica G Scotchie; Ricardo F Savaris; Caitlin E Martin; Steven L Young
Journal:  Reprod Sci       Date:  2014-05-12       Impact factor: 3.060

Review 6.  CB2 receptors in reproduction.

Authors:  M Maccarrone
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 7.  Childhood medical and behavioral consequences of maternal cocaine use.

Authors:  L Singer; K Farkas; R Kliegman
Journal:  J Pediatr Psychol       Date:  1992-08

Review 8.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

9.  Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis.

Authors:  Emmalee S Bandstra; April L Vogel; Connie E Morrow; Lihua Xue; James C Anthony
Journal:  Subst Use Misuse       Date:  2004-01       Impact factor: 2.164

10.  Expressive and receptive language functioning in preschool children with prenatal cocaine exposure.

Authors:  Connie E Morrow; April L Vogel; James C Anthony; Audrey Y Ofir; Ana T Dausa; Emmalee S Bandstra
Journal:  J Pediatr Psychol       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.